DaVita Inc. (NYSE:DVA) Stock Holdings Reduced by Prudential PLC

Prudential PLC lessened its holdings in shares of DaVita Inc. (NYSE:DVA - Free Report) by 61.5% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 7,624 shares of the company's stock after selling 12,195 shares during the quarter. Prudential PLC's holdings in DaVita were worth $1,140,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. SBI Securities Co. Ltd. acquired a new position in shares of DaVita during the fourth quarter valued at approximately $41,000. Quarry LP acquired a new position in shares of DaVita during the 3rd quarter valued at $60,000. Venturi Wealth Management LLC raised its stake in shares of DaVita by 59.8% in the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company's stock worth $61,000 after buying an additional 152 shares in the last quarter. Versant Capital Management Inc lifted its holdings in shares of DaVita by 58.7% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock valued at $68,000 after buying an additional 169 shares during the period. Finally, Blue Trust Inc. boosted its stake in DaVita by 39.7% during the fourth quarter. Blue Trust Inc. now owns 461 shares of the company's stock valued at $76,000 after buying an additional 131 shares in the last quarter. Institutional investors own 90.12% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts have weighed in on DVA shares. Sanford C. Bernstein set a $184.00 price target on shares of DaVita in a report on Friday, February 21st. StockNews.com raised shares of DaVita from a "hold" rating to a "buy" rating in a research note on Thursday. Barclays lifted their price target on shares of DaVita from $164.00 to $169.00 and gave the stock an "equal weight" rating in a research report on Tuesday, February 18th. Finally, Cowen reissued a "hold" rating on shares of DaVita in a research note on Tuesday, February 18th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $166.33.

DaVita Stock Up 1.4 %

Shares of DaVita stock traded up $2.12 during midday trading on Friday, hitting $155.48. The company's stock had a trading volume of 581,032 shares, compared to its average volume of 823,503. DaVita Inc. has a 1-year low of $125.64 and a 1-year high of $179.60. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. The firm has a market capitalization of $12.44 billion, a P/E ratio of 14.48, a PEG ratio of 1.07 and a beta of 1.04. The stock has a 50-day simple moving average of $152.13 and a 200-day simple moving average of $156.59.

DaVita (NYSE:DVA - Get Free Report) last released its earnings results on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. As a group, sell-side analysts expect that DaVita Inc. will post 10.76 earnings per share for the current year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.